These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 11583196

  • 1. Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions.
    Yamada Y, Shirao K, Ohtsu A, Boku N, Hyodo I, Saitoh H, Miyata Y, Taguchi T.
    Ann Oncol; 2001 Aug; 12(8):1133-7. PubMed ID: 11583196
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of weekly paclitaxel by one-hour infusion for advanced gastric cancer.
    Emi Y, Yamamoto M, Takahashi I, Orita H, Kakeji Y, Kohnoe S, Maehara Y.
    Surg Today; 2008 Aug; 38(11):1013-20. PubMed ID: 18958560
    [Abstract] [Full Text] [Related]

  • 3. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
    Shitara K, Takashima A, Fujitani K, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Makari Y, Amagai K, Ueda S, Yoshida K, Shimodaira H, Nishina T, Tsuda M, Kurokawa Y, Tamura T, Sasaki Y, Morita S, Koizumi W.
    Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):277-287. PubMed ID: 28404157
    [Abstract] [Full Text] [Related]

  • 4. Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
    Berger MJ, Vargo C, Vincent M, Shaver K, Phillips G, Layman R, Macrae E, Mrozek E, Ramaswamy B, Wesolowski R, Shapiro CL, Lustberg MB.
    Support Care Cancer; 2015 Jul; 23(7):2019-24. PubMed ID: 25519756
    [Abstract] [Full Text] [Related]

  • 5. [Usefulness of weekly administration of paclitaxel for advanced or recurrent gastric cancer].
    Egawa T, Kubota T, Nagashima A, Doi M, Kitano M, Hayashi S, Yoshii H, Saikawa Y, Kitajima M.
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):877-81. PubMed ID: 15222104
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Paclitaxel administered by 1-hour infusion. Preliminary results of a phase I/II trial comparing two schedules.
    Hainsworth JD, Greco FA.
    Cancer; 1994 Aug 15; 74(4):1377-82. PubMed ID: 7914470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 14. A simplified premedication schedule for 1-hour paclitaxel administration.
    Tsavaris N, Kosmas C, Vadiaka M.
    J Support Oncol; 2005 Oct 15; 3(1):77-81. PubMed ID: 15724950
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.
    Kim YH, Shin SW, Kim BS, Kim JH, Kim JG, Mok YJ, Kim CS, Rhyu HS, Hyun JH, Kim JS.
    Cancer; 1999 Jan 15; 85(2):295-301. PubMed ID: 10023695
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions.
    Bookman MA, Kloth DD, Kover PE, Smolinski S, Ozols RF.
    Ann Oncol; 1997 Jun 15; 8(6):611-4. PubMed ID: 9261533
    [Abstract] [Full Text] [Related]

  • 18. Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).
    Sato K, Inoue K, Saito T, Kai T, Mihara H, Okubo K, Koh J, Mochizuki H, Tabei T, Saitama Breast Cancer Clinical Study Group.
    Jpn J Clin Oncol; 2003 Aug 15; 33(8):371-6. PubMed ID: 14523055
    [Abstract] [Full Text] [Related]

  • 19. Intravenous prophylaxis for paclitaxel-related hypersensitivity reactions.
    Bookman MA, Kloth DD, Kover PE, Smolinski S, Ozols RF.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-13-S19-15. PubMed ID: 9427258
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.
    Vogt HG, Kolotas C, Martin T, Schneider LV, Goes-Schmieder R, Mitrou PS, Diergarten K, Kober B, Zamboglou N.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 16):120-3. PubMed ID: 9007138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.